Patent · US Active

Peptide or peptide complex binding to ALPHA2 integrin and methods and uses involving the same

US9234039B2 · kind B2 · utility

1Cited by

5References

17Claims

0Family size

Assignee

Sanofi · FR

Inventors

Carsten Corvey · Frankfurt am Main, DE
Horst Blum · Frankfurt, DE
Beatrice Cameron · Paris, FR
Tarik Dabdoubi · Paris, FR
Stéphanie DECARY · Paris, FR
Nicolas Baurin · Arpajon, FR
David Papin · Paris, FR
Christian Lange · Frankfurt am Main, DE

Key dates

Filing date	Aug 30, 2011
Grant date	Jan 12, 2016
Priority date	—
Expiry date	Nov 4, 2031

Classification

Technology area (CPC G)Physics
CPC primaryG01N2333/7055
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

The present invention relates to a peptide or peptide complex binding to α2 integrin, to one or more nucleic acid(s) coding for the peptide or peptide complex, a recombinant cell producing the peptide or peptide complex, a method for producing the peptide or peptide complex, a pharmaceutical composition comprising the peptide or peptide complex or the nucleic acid(s) for use as a medicament, a method for detecting α2 integrin and a screening method.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.